KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash from Operations (2016 - 2025)

Novavax (NVAX) has 16 years of Cash from Operations data on record, last reported at 39440000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations rose 77.22% year-over-year to 39440000.0; the TTM value through Dec 2025 reached 244600000.0, down 180.3%, while the annual FY2025 figure was 244600000.0, 180.3% down from the prior year.
  • Cash from Operations reached 39440000.0 in Q4 2025 per NVAX's latest filing, down from 107804000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 663085000.0 in Q1 2021 and bottomed at 342408000.0 in Q4 2021.
  • Average Cash from Operations over 5 years is 56941050.0, with a median of 122639000.0 recorded in 2022.
  • The widest YoY moves for Cash from Operations: up 2969.26% in 2021, down 2087.83% in 2021.
  • A 5-year view of Cash from Operations shows it stood at 342408000.0 in 2021, then surged by 65.59% to 117816000.0 in 2022, then crashed by 50.05% to 176781000.0 in 2023, then grew by 2.05% to 173163000.0 in 2024, then skyrocketed by 77.22% to 39440000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 39440000.0 in Q4 2025, 107804000.0 in Q3 2025, and 127462000.0 in Q2 2025.